| 1 |
33509441 |
10.1053/j.seminhematol.2020.11.008 |
2022 |
A pilot clinical trial of oral tetrahydrouridine/decitabine for noncytotoxic epigenetic therapy of chemoresistant lymphoid malignancies. |
CDKN2A |
| 2 |
33870156 |
10.1016/j.jhepr.2021.100250 |
2022 |
Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the <i>Mdr2</i> <sup><i>-/-</i></sup> mouse. |
CDKN2A |
| 3 |
33932086 |
10.1002/1878-0261.12964 |
2022 |
An in vivo genome-wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer. |
CDKN2A |
| 4 |
34115902 |
10.1111/ced.14798 |
2022 |
The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL-1 cell growth. |
CDKN2A |
| 5 |
34217275 |
10.1186/s12920-021-01023-9 |
2022 |
Hypodiploidy in a pediatric patient of T-cell acute lymphoblastic leukemia: a case report. |
CDKN2A |
| 6 |
34308104 |
10.1093/jncics/pkab007 |
2022 |
Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study. |
CDKN2A |
| 7 |
34369425 |
10.1097/FPC.0000000000000451 |
2022 |
The functional role of inherited CDKN2A variants in childhood acute lymphoblastic leukemia. |
CDKN2A |
| 8 |
34371436 |
10.1016/j.leukres.2021.106683 |
2022 |
Proposal and clinical application of molecular genetic risk scoring system, MRplus, for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre. |
CDKN2A |
| 9 |
34440292 |
10.3390/genes12081118 |
2022 |
T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness. |
CDKN2A |
| 10 |
34448823 |
10.1182/bloodadvances.2021004212 |
2022 |
The molecular hallmarks of primary and secondary vitreoretinal lymphoma. |
CDKN2A |
| 11 |
34591292 |
10.1007/s12185-021-03229-0 |
2022 |
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation. |
CDKN2A |
| 12 |
34657128 |
10.1038/s41375-021-01448-2 |
2022 |
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. |
CDKN2A |
| 13 |
34670378 |
10.21037/apm-21-2256 |
2022 |
Neurolymphomatosis of multifocal peripheral nerve involvement: a case report. |
CDKN2A |
| 14 |
34727170 |
10.1182/bloodadvances.2021005522 |
2022 |
Decreased IL-10 accelerates B-cell leukemia/lymphoma in a mouse model of pediatric lymphoid leukemia. |
CDKN2A |
| 15 |
34787376 |
10.1002/cnr2.1587 |
2022 |
Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia. |
CDKN2A |
| 16 |
34807923 |
10.1371/journal.pone.0259674 |
2022 |
Establishment of the TBX-code reveals aberrantly activated T-box gene TBX3 in Hodgkin lymphoma. |
CDKN2A |
| 17 |
34808593 |
10.1016/j.cancergen.2021.10.003 |
2022 |
Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation. |
CDKN2A |
| 18 |
34821038 |
10.1111/ijlh.13769 |
2022 |
T cell lymphoblastic lymphoma with uncommon CD20 expression. |
CDKN2A |
| 19 |
34940123 |
10.3390/cimb43030149 |
2022 |
Molecular Genetics of Pre-B Acute Lymphoblastic Leukemia Sister Cell Lines during Disease Progression. |
CDKN2A |
| 20 |
34957727 |
10.2478/raon-2021-0050 |
2022 |
Clinical impacts of copy number variations in B-cell differentiation and cell cycle control genes in pediatric B-cell acute lymphoblastic leukemia: a single centre experience. |
CDKN2A |
| 21 |
34980830 |
10.1097/PAS.0000000000001859 |
2022 |
Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System: An Analysis of 11 Cases Using Targeted Gene Sequencing. |
CDKN2A |
| 22 |
35028710 |
10.1007/s00428-021-03265-5 |
2022 |
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas. |
CDKN2A |
| 23 |
35074700 |
10.1016/j.prp.2022.153772 |
2022 |
Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected! |
CDKN2A |
| 24 |
35115489 |
10.1038/s41467-022-28218-7 |
2022 |
An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia. |
CDKN2A |
| 25 |
35117001 |
10.21037/tcr.2019.10.04 |
2022 |
Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. |
CDKN2A |
| 26 |
35117454 |
10.21037/tcr.2019.12.79 |
2022 |
MicorRNA-148b inhibits cell proliferation and facilitates cell apoptosis by regulating DNA Methyltransferase 1 in endometrial cancer. |
CDKN2A |
| 27 |
35142151 |
10.3324/haematol.2021.279908 |
2022 |
A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas. |
CDKN2A |
| 28 |
35247197 |
10.1007/s12094-022-02781-3 |
2022 |
Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia. |
CDKN2A |
| 29 |
35373885 |
10.1002/pbc.29575 |
2022 |
Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas. |
CDKN2A |
| 30 |
35538064 |
10.1038/s41467-022-30050-y |
2022 |
The genomic and transcriptional landscape of primary central nervous system lymphoma. |
CDKN2A |
| 31 |
35726642 |
10.1161/HYPERTENSIONAHA.122.19137 |
2022 |
Cathepsin K Deficiency Prevented Kidney Damage and Dysfunction in Response to 5/6 Nephrectomy Injury in Mice With or Without Chronic Stress. |
CDKN2A |
| 32 |
35910501 |
10.6004/jadpro.2022.13.5.7 |
2022 |
An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia. |
CDKN2A |
| 33 |
35932035 |
10.1186/s12920-022-01325-6 |
2022 |
Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis. |
CDKN2A |
| 34 |
36000950 |
10.1002/pbc.29926 |
2022 |
Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma. |
CDKN2A |
| 35 |
36006308 |
10.3390/vetsci9080393 |
2022 |
Simultaneous Analysis of the p16 Gene and Protein in Canine Lymphoma Cells and Their Correlation with pRb Phosphorylation. |
CDKN2A |
| 36 |
25289094 |
10.3892/ol.2014.2481 |
2021 |
Knockdown of DNA methyltransferase-1 inhibits proliferation and derepresses tumor suppressor genes in myeloma cells. |
CDKN2A |
| 37 |
28123872 |
10.1080/2162402X.2016.1237327 |
2021 |
IL-15 enhances the antitumor effect of human antigen-specific CD8<sup>+</sup> T cells by cellular senescence delay. |
CDKN2A |
| 38 |
31383960 |
10.1038/s41379-019-0323-8 |
2021 |
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. |
CDKN2A |
| 39 |
31631728 |
10.1080/10428194.2019.1675877 |
2021 |
The role of MYC in the transformation and aggressiveness of 'indolent' B-cell malignancies. |
CDKN2A |
| 40 |
31701788 |
10.1080/17474086.2020.1690987 |
2021 |
Histological transformation in malignant lymphoma: a possible role of PET/CT and circulating tumor DNA as noninvasive diagnostic tools. |
CDKN2A |
| 41 |
31734690 |
10.1093/carcin/bgz185 |
2021 |
Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells. |
CDKN2A |
| 42 |
32255708 |
10.1080/10428194.2020.1747068 |
2021 |
Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy. |
CDKN2A |
| 43 |
32277542 |
10.1002/gcc.22849 |
2021 |
Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A/B loss, and TP53 mutations: A multi-institutional study. |
CDKN2A |
| 44 |
32592278 |
10.1002/gcc.22882 |
2021 |
Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol. |
CDKN2A |
| 45 |
32598477 |
10.1182/bloodadvances.2019001350 |
2021 |
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. |
CDKN2A |
| 46 |
32701692 |
10.1097/DAD.0000000000001632 |
2021 |
A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis. |
CDKN2A |
| 47 |
32751805 |
10.3390/cancers12082120 |
2021 |
Concurrent <i>TP53</i> and <i>CDKN2A</i> Gene Aberrations in Newly Diagnosed Mantle Cell Lymphoma Correlate with Chemoresistance and Call for Innovative Upfront Therapy. |
CDKN2A |
| 48 |
32779615 |
10.3960/jslrt.20019 |
2021 |
Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. |
CDKN2A |
| 49 |
32861279 |
10.1016/j.hoc.2020.05.003 |
2021 |
Cell Cycle Dysregulation in Mantle Cell Lymphoma: Genomics and Therapy. |
CDKN2A |
| 50 |
32918521 |
10.1002/pbc.28704 |
2021 |
Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemia. |
CDKN2A |
| 51 |
32981916 |
10.3960/jslrt.20021 |
2021 |
Integrative genomic analysis focused on cell cycle genes for MYC-driven aggressive mature B-cell lymphoma. |
CDKN2A |
| 52 |
33054126 |
10.3324/haematol.2020.262659 |
2021 |
<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS). |
CDKN2A |
| 53 |
33226554 |
10.1007/s12094-020-02504-6 |
2021 |
Expression and DNA methylation profiles of EZH2-target genes in plasma exosomes and matched primary tumor tissues of the patients with diffuse large B-cell lymphoma. |
CDKN2A |
| 54 |
33306218 |
10.1002/ajh.26069 |
2021 |
CDKN2A deletions are associated with poor outcomes in 101 adults with T-cell acute lymphoblastic leukemia. |
CDKN2A |
| 55 |
33316538 |
10.1016/j.neo.2020.11.010 |
2021 |
U-RT1 - A new model for Richter transformation. |
CDKN2A |
| 56 |
33357483 |
10.1016/S2352-3026(20)30353-7 |
2021 |
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study. |
CDKN2A |
| 57 |
33369444 |
10.31557/APJCP.2020.21.12.3493 |
2021 |
Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with Prognosis. |
CDKN2A |
| 58 |
33435487 |
10.3390/genes12010079 |
2021 |
The Yin and Yang-Like Clinical Implications of the <i>CDKN2A/ARF/CDKN2B</i> Gene Cluster in Acute Lymphoblastic Leukemia. |
CDKN2A |
| 59 |
33528622 |
10.1007/s00428-021-03022-8 |
2021 |
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features. |
CDKN2A |
| 60 |
33538126 |
10.1111/ijlh.13477 |
2021 |
Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases. |
CDKN2A |
| 61 |
33538150 |
10.3324/haematol.2020.260935 |
2021 |
A multicenter total therapy strategy for <i>de novo</i> adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol. |
CDKN2A |
| 62 |
33538798 |
10.1182/blood.2020005734 |
2021 |
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1. |
CDKN2A |
| 63 |
33541741 |
10.1016/j.arcmed.2020.12.013 |
2021 |
Copy Number Alterations are Associated with the Risk of Very Early Relapse in Pediatric B-lineage Acute Lymphoblastic Leukemia: A Nested Case-control MIGICCL Study. |
CDKN2A |
| 64 |
33720992 |
10.1371/journal.ppat.1009419 |
2021 |
Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes. |
CDKN2A |
| 65 |
33750258 |
10.1080/0284186X.2021.1900908 |
2021 |
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on <i>BCR-ABL1</i>-like subtype. |
CDKN2A |
| 66 |
33775465 |
10.1016/j.blre.2021.100824 |
2021 |
Revisiting Richter transformation in the era of novel CLL agents. |
CDKN2A |
| 67 |
33777778 |
10.3389/fonc.2021.628807 |
2021 |
Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma. |
CDKN2A |
| 68 |
33793571 |
10.1371/journal.pgen.1009395 |
2021 |
Identification of common predisposing loci to hematopoietic cancers in four dog breeds. |
CDKN2A |
| 69 |
33851706 |
10.1042/CS20201498 |
2021 |
In utero and early-life exposure to thirdhand smoke causes profound changes to the immune system. |
CDKN2A |
| 70 |
34098582 |
10.1182/blood.2020007591 |
2021 |
MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia. |
CDKN2A |
| 71 |
34218589 |
10.3760/cma.j.issn.0253-2727.2021.05.015 |
2021 |
[The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients]. |
CDKN2A |
| 72 |
34256839 |
10.1186/s40164-021-00232-3 |
2021 |
Progress in molecular feature of smoldering mantle cell lymphoma. |
CDKN2A |
| 73 |
34258755 |
10.1111/bjh.17639 |
2021 |
Characteristics of genetic alterations of peripheral T-cell lymphoma in childhood including identification of novel fusion genes: the Japan Children's Cancer Group (JCCG). |
CDKN2A |
| 74 |
34340673 |
10.1186/s12885-021-08635-5 |
2021 |
Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia. |
CDKN2A |
| 75 |
34406703 |
10.1002/ajh.26324 |
2021 |
The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study. |
CDKN2A |
| 76 |
34576156 |
10.3390/ijms22189992 |
2021 |
Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy. |
CDKN2A |
| 77 |
34646650 |
10.7759/cureus.17598 |
2021 |
An Aggressive Presentation of Mantle Cell Lymphoma With Unique Molecular Features. |
CDKN2A |
| 78 |
26137003 |
10.3892/ol.2015.2986 |
2020 |
Effect of combined 5-aza-2'deoxycytidine and cisplatin treatment on the P15 lung adenocarcinoma cell line. |
CDKN2A |
| 79 |
28487787 |
10.1155/2017/5083463 |
2020 |
EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in <i>ASXL1</i>, <i>BCOR</i>, <i>CDKN2A</i>, <i>NF1</i>, and <i>TP53</i>. |
CDKN2A |
| 80 |
29670052 |
10.3390/diagnostics8020026 |
2020 |
Aneuploid CTC and CEC. |
CDKN2A |
| 81 |
29966470 |
10.1080/10428194.2018.1482542 |
2020 |
Deletion of CDKN2A/B is associated with inferior relapse free survival in pediatric B cell acute lymphoblastic leukemia. |
CDKN2A |
| 82 |
30171027 |
10.3324/haematol.2017.186320 |
2020 |
Clinical and molecular characteristics of <i>MEF2D</i> fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in <i>MEF2D-HNRNPH1</i> gene fusion. |
CDKN2A |
| 83 |
30190342 |
10.3324/haematol.2018.196055 |
2020 |
Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. |
CDKN2A |
| 84 |
30250579 |
10.3892/ol.2018.9268 |
2020 |
Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway. |
CDKN2A |
| 85 |
30402386 |
10.1016/j.rmcr.2018.10.020 |
2020 |
An unusual case of chylothorax. |
CDKN2A |
| 86 |
30470842 |
10.1038/s41417-018-0057-7 |
2020 |
Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma. |
CDKN2A |
| 87 |
30586141 |
10.1001/jamadermatol.2018.3662 |
2020 |
Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma. |
CDKN2A |
| 88 |
30592434 |
10.1080/07853890.2018.1564359 |
2020 |
Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis. |
CDKN2A |
| 89 |
30723112 |
10.1182/bloodadvances.2018027672 |
2020 |
<i>MYD88</i> L265P mutation and <i>CDKN2A</i> loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas. |
CDKN2A |
| 90 |
30874617 |
10.1038/s41598-019-41078-4 |
2020 |
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia. |
CDKN2A |
| 91 |
30902917 |
10.1634/theoncologist.2018-0572 |
2020 |
Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer. |
CDKN2A |
| 92 |
30915242 |
10.1155/2019/3540487 |
2020 |
Primary Cutaneous T-Cell Lymphoblastic Lymphoma: Case Report and Literature Review. |
CDKN2A |
| 93 |
30938769 |
10.1093/labmed/lmz008 |
2020 |
BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use. |
CDKN2A |
| 94 |
30938820 |
10.1093/jnci/djz043 |
2020 |
Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children. |
CDKN2A |
| 95 |
30963600 |
10.1002/ajh.25487 |
2020 |
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. |
CDKN2A |
| 96 |
31092896 |
10.1038/s41375-019-0473-1 |
2020 |
Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling. |
CDKN2A |
| 97 |
31093876 |
10.1007/s11033-019-04856-x |
2020 |
The prognostic impact of hypermethylation for a panel of tumor suppressor genes and cell of origin subtype on diffuse large B-cell lymphoma. |
CDKN2A |
| 98 |
31123088 |
10.1158/0008-5472.CAN-18-2480 |
2020 |
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress. |
CDKN2A |
| 99 |
31202078 |
10.1016/j.leukres.2019.05.013 |
2020 |
Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients. |
CDKN2A |
| 100 |
31228652 |
10.1016/j.leukres.2019.05.009 |
2020 |
Prognostic gene alterations and clonal changes in childhood B-ALL. |
CDKN2A |
Datasets
Models
